FDA Inspection 1085155 — SpecGx, LLC

SpecGx, LLC — FEI 3005275960

The FDA completed an inspection of SpecGx, LLC on Mar 6, 2019 in Webster Groves, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 6, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Webster Groves, MO (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.